Innovation Active Updated Aug 1, 2026
The alt-protein funding winter
The money meant to build the post-animal economy went from gold rush to drought: alternative-protein startups raised a record $5.1 billion in 2021, then less every year since, down to $881 million in 2025, the first sub-billion year since 2018. The winter is culling weak companies and repricing strong ones. This storyline tracks who still raises, who folds, and whether growing public funding, $2.5 billion in 2025, and leaner business models can carry the field to products that win on taste and price.
The story so far
-
Aug 1, 2026 Latest
Beyond Meat hired a former Olam executive as chief operating officer as the company braces for another quarterly sales decline. Livekindly Collective agreed to acquire plant-based business Dalco Food from Hilton Food Group for £5.4 million ($7.3 million), its second European plant-based acquisition this year after Greenforce Future Food.
-
Jul 28, 2026
Canada's No Meat Factory closed its two-year-old Stanwood, Washington plant, which it had paid $19.4 million for in 2023, laying off 123 workers including CEO Michael Parks, effective September 16. North American plant-based meat startup investment fell from $1.5 billion in 2022 to $450 million in 2025.
-
Jul 27, 2026
Estonian government metrology institute Metrosert signed a 2 million euro ($2.3 million) contract with construction firm Savekate to build a shared synbio pilot plant, giving alt-protein and novel-food startups shared testing infrastructure instead of building their own plants. The plant is expected to be complete by the end of the year.
-
Jul 26, 2026
The Bezos Centre for Sustainable Protein and Imperial College London launched a 12-month equity-free accelerator linking alt-protein startups to pilot budgets from corporate partners Danone, Mars, Cargill and Kerry.
-
Jul 24, 2026
The auction for Believer Meats' shuttered Wilson, North Carolina plant was pushed to August 17, with bids closing August 10 and a sale hearing August 20, after numerous discussions with other interested parties beyond UPSIDE Foods' $50 million stalking-horse bid. Contractor Gray Construction sued over $36.4 million it says it is still owed for building the plant.
-
Jul 23, 2026
Oatly raised its 2026 revenue guidance to 8-10% growth after Q2 revenue jumped 15.2% to $240.1 million and its net loss narrowed to $31.3 million from $55.9 million a year earlier, sending shares up more than 19%. Israeli molecular-farming startup Plantopia raised $9 million to grow dairy casein proteins inside sprouted oats, targeting $15-20 per kg, on par with cow-derived casein.
-
Jul 22, 2026
UPSIDE Foods submitted a $50 million baseline bid for Believer Meats' shuttered North Carolina production facility, the trustee handling the sale said, as bids for the collapsed company's cultivated-meat patents were extended to August 5 due to a high level of interest. Believer Meats had raised $400 million before entering receivership in December, and over $150 million was spent building the North Carolina plant.
-
Jul 21, 2026
Japan pledged $6.2 billion for alt-protein "new foods" through 2040 inside a $2.3 trillion, 17-sector national growth plan, with $60 billion earmarked across the plan's four food-tech-related sectors. Cultivated meat was notably absent from the draft, and Japan's Council for Japan's Growth Strategy still must finalize sector-by-sector budgets before the roadmap takes effect.
-
Jul 18, 2026
Swedish precision-fermentation startup Melt&Marble launched its first commercial product, Marble7, an animal- and palm-oil-free designer fat for skincare and personal care formulators, after raising more than $17 million to date including an $8.5 million Series A closed in December.
-
Jul 16, 2026
Cultivated meat pioneer Believer Meats, dark since a funding collapse last year, began auctioning off its assets with no closing date announced. Separately, Beyond Meat posted 25 open roles in the first half of 2026, up from just 8 across all of 2025, as alt-protein employers shifted hiring from R&D toward commercial roles chasing revenue, with commercial postings making up 34.1% of H1 2026 alt-protein jobs versus 23.7% technical.
-
Jul 11, 2026
Carbon-to-fat startup Savor signed a two-year agreement with Swedish fats giant AAK, which also took an equity stake in the smaller company, to develop specialty fats for dairy alternatives and bakery made from captured CO2, green hydrogen and methane instead of farm inputs.
-
Jul 9, 2026
Novonesis, the Danish biotech formed from the Novozymes-Chr. Hansen merger, signed an exclusive agreement to manufacture and commercialize TurtleTree's precision-fermented lactoferrin (LF+) for early-life nutrition, with Mitsui Chemicals co-investing; TurtleTree holds the first global FDA no-questions letter for the ingredient and had cut to a skeleton staff of nine in January 2025, making the deal the clearest signal a precision fermentation startup navigated the funding winter to a commercial manufacturing partnership [100]. PARIMA and Vow completed a multi-ton cultivated meat production run in a 22,000-liter bioreactor, and Arthur D. Little analysis concluded the primary technical barrier
-
Jul 8, 2026
Mosa Meat secured a €875,000 loan from Invest International, the Dutch government's development finance institution, for international market entry, and disclosed a pivot toward hybrid products combining cultivated fat with plant protein rather than whole-muscle cultivated beef, citing the bioreactor scale-up costs whole-muscle requires. The company operates a 1,000L bioreactor in Maastricht. Public development capital is now visibly filling the space private VC vacated in cultivated meat.
-
Apr 21, 2026
GFI's 2026 State of the Industry reports counted $881 million invested in 2025, down 20 percent and below $1 billion for the first time since 2018. Plant-based rose to $450 million, flattered by Beyond Meat's $100 million debt round; fermentation fell to $357 million; cultivated meat took just $74 million. The counterweights: government funding grew from $700 million in 2021 to $2.5 billion in 2025, and global plant-based retail sales rose 3 percent to $28.9 billion.
-
Feb 18, 2026
The survivors' pattern came into focus: the EVERY Company raised $55 million for precision-fermented egg proteins it already sells at scale, and MATR Foods took $23.2 million to expand fungal-fermented meat production. Investors' new bar, per FoodNavigator: process reliability, contracted revenue and scalable operations. 'Capital isn't missing, but it is harder to secure.'
-
Oct 13, 2025
Beyond Meat shares plunged more than 60 percent after it announced the early settlement of a debt exchange: about 97 percent of holders of its zero-coupon 2027 convertible notes took roughly $208.7 million of new 7 percent notes due 2030 plus more than 316 million new shares. The swap eased a debt load of about $1.3 billion at the end of 2024, at the price of massive dilution for 2019's hottest IPO.
-
May 2, 2025
Court filings revealed that Meati Foods, the mycelium-meat maker that had raised about $450 million and was valued at $650 million in 2022, would be sold for $4 million. Its lender had swept two thirds of the company's cash in late February over a technical default, forcing layoff warnings to all 150 staff in the middle of a fundraise.
-
Apr 29, 2025
The 2024 numbers: $1.1 billion invested, down 27 percent. Plant-based startups fell 64 percent to $309 million, cultivated meat took $139 million, its lowest total since 2019, and fermentation was the lone bright spot, with venture investment up 43 percent on the year, led by Meati's $100 million round. Global plant-based retail sales still grew 5 percent to $28.6 billion.
-
Apr 17, 2024
GFI's State of the Industry reports put 2023 investment at $1.6 billion, down another 44 percent: $907 million to plant-based companies, $515 million to fermentation and $226 million to cultivated meat. Two straight down years turned the correction into a winter.
-
Dec 31, 2022
The correction arrived: alt-protein companies raised $2.9 billion in 2022, down 42 percent year over year and in line with a broad venture pullback. GFI counted $14.2 billion in private capital across the sector's first decade and argued the long-term case was intact.
-
Dec 31, 2021
Alternative-protein companies closed the boom's biggest year with a record $5.1 billion raised in 2021, per the Good Food Institute, after funding had almost tripled to $3.2 billion in 2020.
-
May 2, 2019
Beyond Meat went public at $25 a share and closed its first day at $65.75, up 163 percent, the strongest debut for a US listing raising at least $200 million since before the 2008 financial crisis. The IPO raised $241 million and valued the plant-based meat maker at about $3.8 billion, making alt protein the hottest theme in food investing.
Get the next update to this storyline by email.
When this fight moves, the new beat lands on this timeline and in the morning brief the same day. Follow it free, and you will know before the feeds do.
Free, every morning. Unsubscribe in one click.